FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292117670> ?p ?o ?g. }

• W4292117670 abstract "SARS-CoV-2, the newly emerged virus of the Coronaviridae family is causing havoc worldwide. The novel coronavirus 2019 was first reported in Wuhan, China marked as the third highly infectious pathogenic virus of the twenty-first century. The typical manifestations of COVID-19 include cough, sore throat, fever, fatigue, loss of sense of taste and difficulties in breathing. Large numbers of SARS-CoV-2 infected patients have mild to moderate symptoms, however severe and life-threatening cases occur in about 5–10% of infections with an approximately 2% mortality rate. For the treatment of SARS-CoV-2, the use of neutralizing monoclonal antibodies (mAbs) could be one approach. The receptor binding domain (RBD) and N-terminal domain (NTD) situated on the peak of the spike protein (S-Protein) of SARS-CoV-2 are immunogenic in nature, therefore, can be targeted by neutralizing monoclonal antibodies. Several bioinformatics approaches highlight the identification of novel SARS-CoV-2 epitopes which can be targeted for the development of COVID-19 therapeutics. Here we present a summary of neutralizing mAbs isolated from COVID-19 infected patients which are anticipated to be a better therapeutic alternative against SARS-CoV-2. However, provided the vast escalation of the disease worldwide affecting people from all strata, affording expensive mAb therapy will not be feasible. Hence other strategies are also being employed to find suitable vaccine candidates and antivirals against SARS-CoV-2 that can be made easily available to the population." @default.
• W4292117670 created "2022-08-17" @default.
• W4292117670 creator A5017890130 @default.
• W4292117670 creator A5028031729 @default.
• W4292117670 creator A5050031621 @default.
• W4292117670 creator A5052257511 @default.
• W4292117670 date "2022-08-17" @default.
• W4292117670 modified "2023-10-16" @default.
• W4292117670 title "Monoclonal antibodies: a remedial approach to prevent SARS-CoV-2 infection" @default.
• W4292117670 cites W1963838989 @default.
• W4292117670 cites W2084534408 @default.
• W4292117670 cites W2092503684 @default.
• W4292117670 cites W2122089494 @default.
• W4292117670 cites W2129854963 @default.
• W4292117670 cites W2611116815 @default.
• W4292117670 cites W2772437484 @default.
• W4292117670 cites W2791709730 @default.
• W4292117670 cites W2892148921 @default.
• W4292117670 cites W2915405849 @default.
• W4292117670 cites W2998881619 @default.
• W4292117670 cites W3006703916 @default.
• W4292117670 cites W3006907181 @default.
• W4292117670 cites W3007643904 @default.
• W4292117670 cites W3008876765 @default.
• W4292117670 cites W3009932851 @default.
• W4292117670 cites W3012088820 @default.
• W4292117670 cites W3013270768 @default.
• W4292117670 cites W3014067025 @default.
• W4292117670 cites W3015321334 @default.
• W4292117670 cites W3016699494 @default.
• W4292117670 cites W3017300461 @default.
• W4292117670 cites W3021621689 @default.
• W4292117670 cites W3023349022 @default.
• W4292117670 cites W3023698680 @default.
• W4292117670 cites W3025744748 @default.
• W4292117670 cites W3030568918 @default.
• W4292117670 cites W3031365196 @default.
• W4292117670 cites W3032255042 @default.
• W4292117670 cites W3033207790 @default.
• W4292117670 cites W3033450058 @default.
• W4292117670 cites W3033635839 @default.
• W4292117670 cites W3033791198 @default.
• W4292117670 cites W3034202401 @default.
• W4292117670 cites W3034370844 @default.
• W4292117670 cites W3034425032 @default.
• W4292117670 cites W3034548712 @default.
• W4292117670 cites W3034816694 @default.
• W4292117670 cites W3035950190 @default.
• W4292117670 cites W3036453504 @default.
• W4292117670 cites W3036529319 @default.
• W4292117670 cites W3041222256 @default.
• W4292117670 cites W3042323010 @default.
• W4292117670 cites W3044050454 @default.
• W4292117670 cites W3045390355 @default.
• W4292117670 cites W3046125961 @default.
• W4292117670 cites W3046368382 @default.
• W4292117670 cites W3048515223 @default.
• W4292117670 cites W3048558989 @default.
• W4292117670 cites W3048657824 @default.
• W4292117670 cites W3083773456 @default.
• W4292117670 cites W3084240008 @default.
• W4292117670 cites W3084300158 @default.
• W4292117670 cites W3087282025 @default.
• W4292117670 cites W3089346069 @default.
• W4292117670 cites W3091938242 @default.
• W4292117670 cites W3093173238 @default.
• W4292117670 cites W3093565226 @default.
• W4292117670 cites W3093768302 @default.
• W4292117670 cites W3093900830 @default.
• W4292117670 cites W3093994474 @default.
• W4292117670 cites W3094419073 @default.
• W4292117670 cites W3094966657 @default.
• W4292117670 cites W3096064145 @default.
• W4292117670 cites W3096658347 @default.
• W4292117670 cites W3098697637 @default.
• W4292117670 cites W3103861847 @default.
• W4292117670 cites W3107112434 @default.
• W4292117670 cites W3107235131 @default.
• W4292117670 cites W3107546404 @default.
• W4292117670 cites W3110918569 @default.
• W4292117670 cites W3111431752 @default.
• W4292117670 cites W3115260439 @default.
• W4292117670 cites W3119881634 @default.
• W4292117670 cites W3120437566 @default.
• W4292117670 cites W3124782715 @default.
• W4292117670 cites W3125712166 @default.
• W4292117670 cites W3129126893 @default.
• W4292117670 cites W3133980772 @default.
• W4292117670 cites W3135505206 @default.
• W4292117670 cites W3154724088 @default.
• W4292117670 cites W3155123963 @default.
• W4292117670 cites W3158608312 @default.
• W4292117670 cites W3158883224 @default.
• W4292117670 cites W3158955064 @default.
• W4292117670 cites W3162168784 @default.
• W4292117670 cites W3187723563 @default.
• W4292117670 cites W3195015299 @default.
• W4292117670 cites W3196273423 @default.
• W4292117670 cites W3198233589 @default.
• W4292117670 cites W3198689144 @default.

• next